Graham K. Dixon is Chairman at Apaxen SA, Chief Scientific Officer of Mithra Pharmaceuticals SA and Head-Research & Development at Zaluvida Holdings Pte Ltd. Dr. Dixon is also on the board of Alligator Bioscience AB and InteRNA Technologies BV.

Dr. Dixon previously occupied the position of Chairman for HepaRegeniX GmbH, Head-Research & Development at AstraZeneca PLC and Head-Research & Development at Zeneca Garden Care (a subsidiary of AstraZeneca PLC), Senior Vice President-Drug Discovery at Galapagos NV and Chief Scientific Officer at Galapagos Genomics NV (a subsidiary of Galapagos NV), CSO, Head-Research & Development at Valerio Therapeutics SA, CSO, Head-Research & Development at Addex Therapeutics Ltd., Chief Scientific Officer of Entomed SA, CSO, Head-Research & Development at Sensorion SA, Chief Strategy Officer for F2G Ltd. and Chief Executive Officer at Neem Biotech Ltd.

He received a doctorate from Swansea University and an undergraduate degree from the University of Bradford.